News Releases

2012
14/05/2012	MERCK SERONO EXTENDS THE EMPLOYEE CONSULTATION PERIOD IN SWITZERLAND Geneva, Switzerland	English French German
09/05/2012	MERCK SERONO: PETACC-8 STUDY OF ERBITUX AS ADJUVANT TREATMENT IN COLON CANCER SHOWS NO BENEFIT AT PRE-SPECIFIED INTERIM ANALYSIS Geneva, Switzerland	English
28/04/2012	MERCK SERONO CONFIRMS ITS DESIRE TO PURSUE A CONSTRUCTIVE DIALOGUE WITH ITS EMPLOYEES AND TO INVOLVE THEIR REPRESENTATIVES Geneva, Switzerland	English French German
24/04/2012	MERCK ANNOUNCES MERCK SERONO IMPLEMENTATION PLANS FOR ITS EFFICIENCY PROGRAM IN SWITZERLAND Geneva, Switzerland	English French German
20/04/2012	MERCK SERONO TO PRESENT NEW DATA ON MULTIPLE SCLEROSIS AT THE AMERICAN ACADEMY OF NEUROLOGY’S 64TH ANNUAL MEETING Geneva, Switzerland Geneva, Switzerland	English French German
15/03/2012	Merck Serono Fertility Treatment Pergoveris® Receives Marketing Approval In Russia Geneva, Switzerland	English French German
03/02/2012	MERCK SERONO AND THRESHOLD ANNOUNCE GLOBAL AGREEMENT TO CO-DEVELOP AND COMMERCIALIZE PHASE III HYPOXIA-TARGETED DRUG TH-302 Geneva, Switzerland	English
30/01/2012	MERCK SERONO TO RAISE DONATION TENFOLD TO ELIMINATE WORM DISEASE Geneva, Switzerland	English French German
25/01/2012	MERCK SERONO RECEIVES EUROPEAN APPROVAL TO EXPAND USE OF REBIF® IN PATIENTS WITH EARLY MULTIPLE SCLEROSIS Geneva, Switzerland	English French German
10/01/2012	MERCK SERONO INITIATES VALIDATION STUDY OF THE FIRST QUALITY-OF-LIFE QUESTIONNAIRE SPECIFIC TO PHENYLKETONURIA Geneva, Switzerland	English French German

2011
13/12/2011	MERCK SERONO HELPS ELIMINATE SCHISTOSOMIASIS IN AFRICA Geneva, Switzerland	English French German
30/11/2011	MERCK SERONO ANNOUNCES WINNER OF GLOBAL DESIGN COMPETITION FOR MULTIPLE SCLEROSIS COMMUNITY Geneva, Switzerland	English French German
25/11/2011	MERCK SERONO SUPPORTS THE CHIMISCOPE: AN EDUCATIONAL LABORATORY TO STIMULATE INTEREST IN CHEMISTRY Geneva, Switzerland	English French German
18/11/2011	MERCK SERONO: CHMP GIVES POSITIVE OPINION FOR EXTENDED INDICATION FOR REBIF® TO TREAT PATIENTS WITH EARLY SIGNS OF MULTIPLE SCLEROSIS Geneva, Switzerland	English French German
14/11/2011	MERCK SERONO TO MARK WORLD DIABETES DAY FOR HIGH RESOLUTION PICTURES OF THE MERCK SERONO HEADQUARTERS LIT IN BLUE, CLICK HERE Geneva, Switzerland	English French German
09/11/2011	MERCK SERONO AND ABLYNX EXPAND THEIR PARTNERSHIP INTO OSTEOARTHRITIS Geneva, Switzerland	English French German
24/10/2011	MERCK SERONO LAUNCHES EASYPOD™ CONNECT IN EUROPE Geneva, Switzerland	English French German
21/10/2011	FOUR FINALISTS OF GLOBAL DESIGN COMPETITION HIGHLIGHT NEED FOR INNOVATIVE SOLUTIONS FOR LIVING BETTER WITH MULTIPLE SCLEROSIS Geneva, Switzerland	English French German
21/10/2011	MERCK SERONO RETURNS RIGHTS FOR SAFINAMIDE TO NEWRON Geneva, Switzerland	English French German
04/10/2011	MERCK SERONO AND ONO PHARMACEUTICAL FORM COLLABORATIONS TO DEVELOP ORAL MULTIPLE SCLEROSIS DRUG AND CANCER IMMUNOTHERAPY Geneva, Switzerland	English French German
28/09/2011	MERCK SERONO ANNOUNCES ABOUT 30,000 PATIENTS TREATED WITH EASYPOD™, FIRST ELECTRONIC GROWTH HORMONE INJECTION DEVICE Geneva, Switzerland	English French German
20/09/2011	MERCK SERONO SUPPORTS CANCER PATIENTS IN THE LAKE GENEVA AREA Geneva, Switzerland	English French German
19/09/2011	MERCK SERONO ACQUIRES RIGHTS TO PI-2301 PROGRAM FOR MULTIPLE SCLEROSIS Geneva, Switzerland	English French German
12/09/2011	MERCKSERONO JOINS THE FONDATION POUR GENEVE IN HONOURING THE RESEARCH ACHIEVED BY PROFESSOR DENIS DUBOULE Geneva, Switzerland	English French German
07/09/2011	MERCK SERONO AND F-STAR TO COLLABORATE IN THE DISCOVERY AND DEVELOPMENT OF NOVEL TARGETED BIOLOGICS Geneva, Switzerland	English French German
07/09/2011	MERCK SERONO ANNOUNCES CREATION OF ONCOLOGY CHAIR IN PARTNERSHIP WITH EPFL Geneva, Switzerland	English French German
12/08/2011	MERCK SERONO: FIRST INNOVATION CUP PROGRAM ENDED SUCCESSFULLY Geneva, Switzerland	English French German
29/07/2011	MERCK SERONO COMPLETES PATIENT ENROLLMENT IN SETTLE, A PHASE III PIVOTAL CLINICAL TRIAL OF SAFINAMIDE IN ADVANCED PARKINSON’S DISEASE Geneva, Switzerland	English French German
11/07/2011	MERCK SERONO JOINED THE BIKE TO WORK CAMPAIGN: "DO SOME GOOD BOTH TO YOUR HEALTH AND TO THE ENVIRONMENT!" Geneva, Switzerland	English French German Italian
07/07/2011	MERCK SERONO STRENGTHENS EXECUTIVE MANAGEMENT TEAM WITH TWO APPOINTMENTS For high resolution picture download click here Geneva, Switzerland	English French German
05/07/2011	MERCK SERONO AWARDS GRANT TO INNOVATIVE RESEARCH PROJECTS IN FERTILITY Geneva, Switzerland	English French German
04/07/2011	MERCK SERONO RECEIVED EUROPEAN APPROVAL FOR THREE PRE-FILLED, READY-TO-USE PEN INJECTORS FOR FERTILITY TREATMENT Geneva, Switzerland	English French German
30/06/2011	MERCK SERONO AND FAST FORWARD ANNOUNCE RECIPIENTS OF FUNDING FOR MULTIPLE SCLEROSIS RESEARCH Geneva, Switzerland	English French German
30/06/2011	MERCK SERONO INITIATES PHASE IIIB EUROPEAN STUDY SPARK IN CHILDREN YOUNGER THAN FOUR YEARS, SUFFERING FROM PHENYLKETONURIA Geneva, Switzerland	English French German
29/06/2011	MERCK SERONO COMPLETES PATIENT ENROLLMENT IN MOTION, A PHASE III PIVOTAL CLINICAL TRIAL OF SAFINAMIDE IN EARLY PARKINSON’S DISEASE Geneva, Switzerland	English French German
29/06/2011	MERCK SERONO SUBMITS APPLICATION FOR EXTENSION OF INDICATION FOR REBIF® IN EUROPE Geneva, Switzerland	English French German
22/06/2011	MERCK SERONO: REGULATORY UPDATE ON CLADRIBINE TABLETS Geneva, Switzerland	English French German
09/06/2011	MERCK SERONO: PATIENT ENROLLMENT COMPLETED FOR CILENGITIDE’S PIVOTAL PHASE III TRIAL CENTRIC Geneva, Switzerland	English
08/06/2011	MERCK SERONO AND AFFECTIS PHARMACEUTICALS ANNOUNCE AN AGREEMENT TO DEVELOP ORAL DRUGS FOR NEURODEGENERATIVE DISEASES Geneva, Switzerland	English French German
04/06/2011	ASCO 2011: ERBITUX INCREASED OVERALL SURVIVAL BY 5.1 MONTHS IN PATIENTS WITH MCRC THAT HAS SPREAD BEYOND THE LIVER Geneva, Switzerland	English
25/05/2011	MERCK SERONO COMMITS TO SUPPORT PEOPLE LIVING WITH MULTIPLE SCLEROSIS AT WORK Geneva, Switzerland	English French German
23/05/2011	MERCK SERONO SUPPORTS FOR THE THIRD YEAR THE INTERNATIONAL THYROID AWARENESS WEEK Geneva, Switzerland	English French German
04/05/2011	MERCK SERONO MET A DISPOSITION LA RESERVE NATURELLE "EN PRAZ-LIBON" A PRO NATURA POUR LA PRESERVATION D’UNE ESPECE MENACEE DE CRAPAUDS Geneva, Switzerland	French German
29/04/2011	MERCK SERONO: NEW PRESENTATION OF CYANOKIT® APPROVED BY U.S. FDA Geneva, Switzerland	English French German
28/04/2011	MERCK SERONO PROVIDES $1.5M GRANT TO MASSACHUSETTS GENERAL HOSPITAL Geneva, Switzerland	English French German
19/04/2011	PUBLICATION OF SURVIVAL BENEFIT IN LEADING JOURNAL EMPHASIZES IMPORTANCE OF ERBITUX IN 1ST LINE MCRC Geneva, Switzerland	English
13/04/2011	MERCK SERONO: DATA ON PARKINSON’S DISEASE INVESTIGATIONAL DRUG SAFINAMIDE TO BE PRESENTED AT AAN 2011 ANNUAL MEETING Geneva, Switzerland	English French German
08/04/2011	MERCK SERONO’S COMMITMENT TO ADVANCE MULTIPLE SCLEROSIS CARE AND RESEARCH UNDERSCORED BY DATA TO BE PRESENTED AT AAN 2011 MEETING Geneva, Switzerland	English French German
31/03/2011	MERCK SERONO AND NEWRON TO BROADEN COLLABORATION ON NEW THERAPIES FOR CENTRAL NERVOUS SYSTEM DISEASES Geneva, Switzerland	English French German
30/03/2011	MERCK SERONO INITIATES STRATEGIC ISRAEL BIOINCUBATOR FUND Geneva, Switzerland	English French German Hebrew
30/03/2011	ERBITUX INDICATION EXTENSION SUBMITTED FOR FIRST-LINE ADVANCED OR METASTATIC NSCLC IN THE EU Geneva, Switzerland	English
15/03/2011	GLOBAL COMPETITION CELEBRATES INNOVATION AND INSPIRATION OF MULTIPLE SCLEROSIS COMMUNITY Geneva, Switzerland	English French German
14/03/2011	MERCK SERONO OPENS DOORS TO BUDDING SCIENTISTS Geneva, Switzerland	English French German Italian
02/03/2011	MERCK SERONO RECEIVES COMPLETE RESPONSE LETTER FROM FDA ON CLADRIBINE TABLETS NEW DRUG APPLICATION Geneva, Switzerland	English French German
15/02/2011	MERCK SERONO LAUNCHES INNOVATION CUP 2011 Geneva, Switzerland	English French German
14/02/2011	MERCK SERONO INITIATES THE FIRST OBSERVATIONAL STUDY TO EVALUATE ADHERENCE AND CLINICAL OUTCOMES OF GROWTH HORMONE SAIZEN® IN PATIENTS USING EASYPOD™ Geneva, Switzerland	English French German
10/02/2011	MERCK SERONO LAUNCHES UNITEMS.NET – A PIONEERING SOCIAL NETWORK AND ONLINE RESOURCE FOR THE MULTIPLE SCLEROSIS COMMUNITY Geneva, Switzerland	English French German
04/02/2011	MERCK SERONO LAUNCH LATEST IN SERIES OF ONGOING DISEASE AWARENESS INITIATIVES Geneva, Switzerland	English
21/01/2011	MERCK SERONO ANNOUNCES OUTCOME OF ITS REQUEST FOR REEXAMINATION OF CHMP OPINION FOR CLADRIBINE TABLETS IN MS Geneva, Switzerland	English French German
17/01/2011	MERCK SERONO AND DOMAIN THERAPEUTICS ANNOUNCE AN AGREEMENT TO DEVELOP DRUGS FOR PARKINSON’S DISEASE Geneva, Switzerland	English French German
12/01/2011	BRIGHTER FUTURES IN MS - INSPIRING SHORT FILM PREMIERES IN BRUSSELS Geneva, Switzerland	English French German
05/01/2011	EXPAND STUDY INVESTIGATING ERBITUX AS 1ST LINE TREATMENT IN ADVANCED GASTRIC CANCER COMPLETES RECRUITMENT Geneva, Switzerland	English

2010
21/12/2010	MERCK SERONO AND PHILOCHEM ENTER INTO RESEARCH AGREEMENT IN FERTILITY Geneva, Switzerland	English French German
17/12/2010	MERCK SERONO AND SANOFI-AVENTIS ANNOUNCE AGREEMENT TO JOINTLY INVESTIGATE NOVEL COMBINATIONS AGAINST CANCER Geneva, Switzerland	English
13/12/2010	MERCK SERONO AND SAN RAFFAELE SCIENTIFIC INSTITUTE TO COLLABORATE ON RESEARCH IN NEURODEGENERATIVE DISEASES Geneva, Switzerland	English French German
26/11/2010	MERCK SERONO ANNOUNCES EXTENSION OF FDA PRIORITY REVIEW PERIOD FOR CLADRIBINE TABLETS FOR THE TREATMENT OF RELAPSING FORMS OF MULTIPLE SCLEROSIS Geneva, Switzerland	English French German
17/11/2010	MERCK SERONO: ENROLLMENT COMPLETED FOR ORACLE MS STUDY OF CLADRIBINE TABLETS IN PATIENTS AT RISK OF DEVELOPING MS Geneva, Switzerland	English French German
15/11/2010	MERCK SERONO: READY-TO-USE FORMULATION OF RECOMBINANT GROWTH HORMONE SAIZEN RECOMMENDED FOR APPROVAL IN EUROPE Geneva, Switzerland	English French German
11/11/2010	FDA APPROVES EGRIFTA™ (TESAMORELIN FOR INJECTION): FIRST AND ONLY TREATMENT FOR THE REDUCTION OF EXCESS ABDOMINAL FAT IN HIV-INFECTED PATIENTS WITH LIPODYSTROPHY Geneva, Switzerland	English French German
04/11/2010	MERCK SERONO ANNOUNCES TOP-LINE RESULTS OF LONG-TERM STUDY OF SAFINAMIDE AS ADD-ON TREATMENT TO LEVODOPA IN ADVANCED PARKINSON’S DISEASE Geneva, Switzerland	English French German
28/10/2010	MERCK SERONO SELLS THÉRAMEX TO TEVA FOR EUR 265 MILLION Geneva, Switzerland	English French German
25/10/2010	MERCK SERONO: REFLEX STUDY RESULTS SHOW TREATMENT WITH REBIF® DELAYS CONVERSION TO MS IN PATIENTS WITH FIRST CLINICAL SIGNS OF THE DISEASE Geneva, Switzerland	English French German
15/10/2010	MERCK SERONO TO INTRODUCE REBIDOSE™, THE REBIF® SINGLE USE PRE-FILLED PEN FOR TREATMENT OF MULTIPLE SCLEROSIS Geneva, Switzerland	English French German
13/10/2010	MERCK SERONO: NEW PRESENTATION OF CYANOKIT® APPROVED IN EUROPE Geneva, Switzerland	English French German
11/10/2010	RESULTS OF A RANDOMIZED PHASE II STUDY WITH ERBITUX IN BREAST CANCER HIGHLIGHTED IN ESMO 2010 PRESIDENTIAL SYMPOSIUM Geneva, Switzerland	English
11/10/2010	SURVEYS HIGHLIGHT ADVANCING CONFIDENCE IN ERBITUX AS ONLY TARGETED TREATMENT TO INCREASE SURVIVAL AND POTENTIAL FOR CURE IN HEAD AND NECK CANCER Geneva, Switzerland	English
11/10/2010	MERCK SERONO NOTIFIED EMA OF ITS INTENTION TO APPEAL CHMP OPINION ON CLADRIBINE TABLETS IN MS Geneva, Switzerland	English French German
11/10/2010	ABLYNX AND MERCK SERONO ENTER INTO SECOND AGREEMENT TO CO-DISCOVER AND CO-DEVELOP NANOBODIES® Geneva, Switzerland	English French German
10/10/2010	EARLY TUMOR SHRINKAGE WITH FIRST-LINE ERBITUX THERAPY LEADS TO LONGEST-EVER MEDIAN SURVIVAL IN KRAS WILD-TYPE MCRC Geneva, Switzerland	English
08/10/2010	MERCK SERONO NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE Geneva, Switzerland	English French German
04/10/2010	NEW DATA FOR ERBITUX IN PREVALENT CANCERS TO BE REVEALED AT ESMO Geneva, Switzerland	English
04/10/2010	MERCK SERONO ANNOUNCES WINNER OF THE REAL MS: YOUR STORY COMPETITION – SCRIPT TO BE MADE INTO AN INTERNATIONAL SHORT FILM ON MULTIPLE SCLEROSIS DIRECTED BY ROBIN SHEPPARD Geneva, Switzerland	English French German
24/09/2010	MERCK SERONO ANNOUNCES CHMP OPINION FOR CLADRIBINE TABLETS IN MS Geneva, Switzerland	English French German
03/09/2010	MERCK SERONO’S CLADRIBINE TABLETS FOR MS APPROVED IN AUSTRALIA Geneva, Switzerland	English French German
01/09/2010	US EDUCATIONAL SUPPORT SERVICE FOR MS COMMUNITY, MS LIFELINES®, REACHES MILESTONE OF SERVICING ONE MILLION IN-BOUND CALLS Geneva, Switzerland	English French German
28/07/2010	MERCK SERONO: FDA GRANTS PRIORITY REVIEW TO CLADRIBINE TABLETS FOR THE TREATMENT OF RELAPSING FORMS OF MS Geneva, Switzerland	English French German
12/07/2010	MERCK SERONO’S CLADRIBINE TABLETS FOR MS APPROVED IN RUSSIA Geneva, Switzerland	English French German
29/06/2010	MERCK SERONO TO AWARD GRANT TO INNOVATIVE RESEARCH PROJECTS IN FERTILITY Geneva, Switzerland	English French German
28/06/2010	FINDINGS FROM GLOBAL SURVEY HELP UNDERSTAND FERTILITY TRENDS AND BARRIERS TO SEEKING MEDICAL HELP AGAINST INFERTILITY Geneva, Switzerland	English French German
25/06/2010	MERCK SERONO CALLS FOR ENTRIES TO REAL MS - YOUR STORY, A GLOBAL COMPETITION TO RAISE AWARENESS OF MULTIPLE SCLEROSIS Geneva, Switzerland	English French German
17/06/2010	Data to Be Presented at ENS 2010 Meeting Underscore Merck Serono’s Commitment to Advance Multiple Sclerosis Care and Research Geneva, Switzerland	English French German
17/06/2010	Merck Serono Resumes Stimuvax Clinical Program in Lung Cancer Geneva, Switzerland	English
10/06/2010	MERCK SERONO: DATA ON SAFINAMIDE TO BE PRESENTED AT THE 14TH MDS MEETING Geneva, Switzerland	English French German
08/06/2010	MERCK SERONO RESUBMITS U.S. APPLICATION FOR CLADRIBINE TABLETS AS A POTENTIAL MS THERAPY Geneva, Switzerland	English French German
05/06/2010	Cilengitide Study Provides Long-Term Follow-up Data in Glioblastoma Patients Receiving Investigational Drug for More Than 4 Years Geneva, Switzerland	English
01/06/2010	GLOBAL SURVEY REVEALS ERBITUX IS NOW A STANDARD OF CARE FOR CONFIRMED KRAS WILD-TYPE METASTATIC COLORECTAL CANCER Geneva, Switzerland	English
26/05/2010	YOUR STORY, YOUR VOICE, YOUR ACHIEVEMENTS, YOUR IDEAS… THIS IS ABOUT LIFE, REAL LIFE, REAL MS Geneva, Switzerland	English French
25/05/2010	INTERNATIONAL THYROID AWARENESS WEEK 2010 TO FOCUS ON THYROID DISORDERS AND PREGNANCY Geneva, Switzerland	English French German
21/05/2010	MERCK SERONO PRESENTS FURTHER EVIDENCE OF SUSTAINED INNOVATION IN ONCOLOGY AT ASCO 2010 Geneva, Switzerland	English
05/05/2010	MERCK SERONO AND FAST FORWARD, LLC ANNOUNCE FIRST RESULTS OF THEIR COLLABORATION TO ADVANCE DRUG DEVELOPMENT IN MULTIPLE SCLEROSIS Geneva, Switzerland	English French German
03/05/2010	MERCK SERONO NAMED ONE OF THE BEST PLACES TO WORK IN INDUSTRY BY THE SCIENTIST MAGAZINE Geneva, Switzerland	English French German
22/04/2010	MERCK SERONO CORPORATE HEADQUARTERS RECEIVES ISO 14001 CERTIFICATION Geneva, Switzerland	English French German
16/04/2010	New Data Supporting Cladribine Tablets as a Potential New Therapeutic Option Presented at the62^nd AAN Annual Meeting Toronto, Canada / Geneva, Switzerland	English French German
31/03/2010	Data from Merck Serono’s Multiple Sclerosis Portfolio to be Presented at the 62^nd Annual Meeting of the American Academy of Neurology Geneva, Switzerland	English French German
29/03/2010	MERCK SERONO: Erbitux Granted extended Use in Japan for First-Line-Treatment for mCRC-Patients with KRAS wild-type Tumors Geneva, Switzerland	English
23/03/2010	MERCK SERONO: STIMUVAX CLINICAL PROGRAM TEMPORARILY SUSPENDED Geneva, Switzerland	English
04/03/2010	CARDIFF UNIVERSITY AND MERCK SERONO LAUNCH INTERNATIONAL SURVEY FOR COUPLES TRYING TO CONCEIVE Geneva, Switzerland	English French German
24/01/2010	ASCO-GI: OVERALL SURVIVAL WITH ERBITUX IS SIGNIFICANTLY IMPROVED IN PATIENTS WITH KRAS WILD-TYPE TUMORS IN CRYSTAL Geneva, Switzerland	English
21/01/2010	TWO-YEAR RESULTS FROM CLARITY STUDY WITH CLADRIBINE TABLETS IN MULTIPLE SCLEROSIS PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE Geneva, Switzerland	English French German
18/01/2010	LE MAGAZINE BILAN PLACE MERCK SERONO EN TETE DE SON PALMARES 2010 DES MEILLEURS EMPLOYEURS DE SUISSE ROMANDE Geneva, Switzerland	French

2009
16/12/2009	MERCK SERONO ANNOUNCES COLLABORATION IN BASIC AND CLINICAL RESEARCH IN MULTIPLE SCLEROSIS Geneva, Switzerland	English French German
10/12/2009	MERCK SERONO STARTS STIMUVAX PHASE III STUDY INSPIRE IN ASIAN PATIENTS WITH ADVANCED NSCLC Geneva, Switzerland	English
10/12/2009	MERCK Serono Initiates KAMPER, The First Pan-European Registry for Patients Under Kuvan® therapy Geneva, Switzerland	English French German
30/11/2009	MERCK SERONO RECEIVES REFUSE TO FILE LETTER FROM FDA ON CLADRIBINE TABLETS NEW DRUG APPLICATION Geneva, Switzerland	English French German
25/11/2009	MERCK SERONO LAUNCHES NEW WEBSITE ON PHENYLKETONURIA Geneva, Switzerland	English French German
19/11/2009	MERCK SERONO TO EXPAND RESEARCH AND DEVELOPMENT PRESENCE IN CHINA Geneva, Switzerland	English French German
19/11/2009	MERCK SERONO: CHMP OPINION FOR ERBITUX IN ADVANCED NON-SMALL CELL LUNG CANCER Geneva, Switzerland	English
16/11/2009	ERBITUX RECOGNIZED BY ASCO AS A 2009 MAJOR CANCER ADVANCE AS FIRST SCCHN TREATMENT TO IMPROVE SURVIVAL IN 30 YEARS Geneva, Switzerland	English
06/11/2009	PETACC-8 STUDY INVESTIGATING ERBITUX AS ADJUVANT TREATMENT IN COLON CANCER COMPLETES RECRUITMENT Geneva, Switzerland	English
15/10/2009	MERCK SERONO REÇOIT LE PRIX DE L’INDUSTRIE DE GENEVE Geneva, Switzerland	French
05/10/2009	MERCK SERONO NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE Geneva, Switzerland	English French German
30/09/2009	MERCK SERONO SUBMITS APPLICATION FOR CLADRIBINE TABLETS AS A POTENTIAL ORAL SHORT-COURSE MULTIPLE SCLEROSIS THERAPY IN THE UNITED STATES Geneva, Switzerland	English French German
23/09/2009	INITIAL COIN STUDY RESULTS PRESENTED AT EUROPEAN ONCOLOGY CONGRESS Geneva, Switzerland	English
16/09/2009	MERCK SERONO GROWTH HORMONE INJECTION DEVICE EASYPOD® APPROVED IN JAPAN Geneva, Switzerland	English French German
14/09/2009	RESULTS OF REBISMART™ USER TRIAL PRESENTED AT 25TH ECTRIMS CONGRESS SHOW BROAD PATIENT ACCEPTANCE OF THE NEW ELECTRONIC DELIVERY DEVICE FOR RELAPSING MULTIPLE SCLEROSIS TREATMENT REBIF® Geneva, Switzerland	English French German
11/09/2009	Results from IMPROVE Study Show MRI Benefits of Rebif® Seen Early in Relapsing-Remitting Multiple Sclerosis Treatment and Sustained Over Time Geneva, Switzerland	English French German
11/09/2009	NEW DATA FROM CLARITY STUDY ON DISEASE ACTIVITY IN MS PATIENTS WHO RECEIVED CLADRIBINE TABLETS PRESENTED AT 25TH ECTRIMS CONGRESS Düsseldorf, Germany, and Geneva, Switzerland	English French German
10/08/2009	EMD SERONO, INC. AND THE UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER ANNOUNCE COLLABORATION FOR PRECLINICAL RESEARCH AND CLINICAL TRIALS Darmstadt, Germany	English
04/08/2009	DATA PRESENTED ON MERCK SERONO’S CILENGITIDE SUPPORT ONGOING CLINICAL EVALUATION IN NSCLC San Francisco, CA, USA/Darmstadt Germany	English
02/08/2009	Merck Serono Presented New Data On the Combination of Erbitux with Standard First-Line Therapy in Patients with NSCLC San Francisco, CA, USA / Geneva, Switzerland	English
31/07/2009	MERCK SERONO Has Requested Re-examination of the CHMP Opinion for Erbitux in Non-Small Cell Lung Cancer Geneva, Switzerland	English
24/07/2009	MERCK SERONO CONSIDERS APPEALING CHMP OPINION ON ERBITUX TREATMENT FOR NON-SMALL CELL LUNG CANCER Geneva, Switzerland	English
23/07/2009	MERCK SERONO SUBMITS APPLICATION FOR CLADRIBINE TABLETS AS MULTIPLE SCLEROSIS THERAPY IN EUROPE Geneva, Switzerland	English French German
16/07/2009	GONAL-F APPROVED IN JAPAN FOR OVULATION INDUCTION IN INFERTILE WOMEN Geneva, Switzerland	English French German
15/07/2009	MERCK SERONO ANNOUNCES LICENSE AGREEMENT WITH BIOWA FOR POTELLIGENT® TECHNOLOGY Darmstadt, Germany	English
01/07/2009	MERCK SERONO LAUNCHES “GLOBAL FERTILITY ACADEMY” TO PROVIDE EDUCATION AND TRAINING FOR THE TREATMENT OF INFERTILITY Geneva, Switzerland	English French German
24/06/2009	MERCK SERONO: LATEST ERBITUX DATA ON METASTATIC COLORECTAL CANCER PRESENTED AT WCGIC UNDERLINE BENEFITS IN PATIENTS WITH KRAS WILD-TYPE TUMORS Barcelona, Spain/Darmstadt, Germany	English
24/06/2009	MERCK SERONO LAUNCHES REBISMART™, FIRST ELECTRONIC INJECTION DEVICE FOR DELIVERY OF MULTIPLE SCLEROSIS TREATMENT REBIF® Geneva, Switzerland	English French German Italian
22/06/2009	NEW DATA FROM CLARITY STUDY PRESENTED AT 19TH ENS MEETING SHOW RAPID AND SUSTAINED MS RELAPSE REDUCTION FOR CLADRIBINE TABLETS Geneva, Switzerland	English French German Italian
22/06/2009	MERCK SERONO INITIATES PHASE III STUDY OF STIMUVAX IN BREAST CANCER Geneva, Switzerland	English
03/06/2009	FIRST PHASE III CLINICAL TRIAL RESULTS OF SAFINAMIDE IN ADVANCED PARKINSON’S DISEASE TO BE PRESENTED AT THE MOVEMENT DISORDER SOCIETY 13TH INTERNATIONAL CONGRESS Geneva, Switzerland	English French German
01/06/2009	UK’S NICE RECOMMENDS USE OF ERBITUX FOR METASTATIC COLORECTAL CANCER PATIENTS Geneva, Switzerland	English
31/05/2009	MERCK SERONO AT FOREFRONT OF EXPLORING MARKERS OF RESPONSE IN CONTINUED EFFORT TO PERSONALIZE CANCER CARE Orlando, FL, USA / Geneva, Switzerland	English
31/05/2009	STUDY SHOWS CILENGITIDE INCREASED OVERALL SURVIVAL IN PATIENTS WITH GLIOBLASTOMA Orlando, FL, USA / Geneva, Switzerland	English
30/05/2009	FOLLOW-UP FROM STIMUVAX STUDY PROVIDES LONG-TERM SAFETY DATA IN ADVANCED LUNG CANCER PATIENTS RECEIVING TREATMENT FOR UP TO 8.2 YEARS Orlando, FL, USA / Geneva, Switzerland	English
25/05/2009	MERCK SERONO To Support First International Thyroid Awareness Week Geneva, Switzerland	English French German
18/05/2009	MERCK SERONO COMMITTED TO INVESTING IN INNOVATION IN THE FERTILITY AREA Geneva, Switzerland	English French German
14/05/2009	MERCK SERONO CHAMPIONS PERSONALIZED CANCER CARE WITH TARGETED THERAPIES Darmstadt, Germany	English
07/05/2009	RESULTS AT ASCO CONGRESS 2009 HIGHLIGHT MERCK SERONO'S LEADERSHIP IN PERSONALIZING CANCER CARE Geneva, Switzerland	English
07/05/2009	MERCK SERONO INITIATES SETTLE, THE SECOND PHASE III CLINICAL TRIAL OF SAFINAMIDE IN ADVANCED PARKINSON’S DISEASE Geneva, Switzerland	English French German
05/05/2009	Merck Serono Launches Glucophage Powder in First European Countries Geneva, Switzerland	English French German
01/05/2009	STUDY PUBLISHED IN THE LANCET SHOWS ERBITUX SIGNIFICANTLY IMPROVES OVERALL SURVIVAL IN 1ST-LINE NSCLC Darmstadt, Germany	English
30/04/2009	Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients with Multiple Sclerosis Geneva, Switzerland	English German French Spanish Italian
21/04/2009	MERCK SERONO LAUNCHES Kuvan ^® in europe Geneva, Switzerland	English German French
02/04/2009	MERCK SERONO: PHASE III ERBITUX DATA PUBLISHED IN NEJM CONFIRMENHANCED EFFICACY IN MCRC PATIENTS IN THE 1ST-LINE SETTING Darmstadt, Germany	English
30/03/2009	Merck Serono: New Phase III Data for Cladribine Tablets to Be Presented at the American Academy of Neurology 61^st ANNUAL MEETING IN APRIL 2009 Geneva, Switzerland	English German French
23/03/2009	MERCK SERONO LAUNCHES STRATEGIC VENTURE CAPITAL FUND Geneva, Switzerland	English German French
18/03/2009	Merck Serono and Fast Forward, LLCAnnounce Collaboration to Accelerate Development of Treatments for Multiple Sclerosis Geneva, Switzerland	English German French
24/02/2009	MERCK SERONO AND AMBRX EXPAND COLLABORATION THROUGH ARX424 MULTIPLE SCLEROSIS DRUG DEVELOPMENT ALLIANCE Geneva, Switzerland	English German French
19/02/2009	EUROPEAN MEDICINES AGENCY RECOMMENDS SUSPENSION OF MARKETING AUTHORIZATION FOR RAPTIVA® Geneva, Switzerland	English German French
16/03/2009	MERCK SERONO EXPANDS CILENGITIDE DEVELOPMENT PROGRAM Darmstadt, Germany	English
03/02/2009	Merck Serono’s Safinamide Significantly Improved Motor Function in Patients with Advanced Parkinson’s Disease in a Phase III Pivotal Trial Geneva, Switzerland	English German French
23/01/2009	MERCK SERONO LAUNCHES ERBITUX IN 1ST-LINE TREATMENT OF HEAD AND NECK CANCER IN EUROPE Antwerp, Belgium	English
23/01/2009	MERCK SERONO´S ORAL INVESTIGATIONAL TREATMENT CLADRIBINE TABLETS FOR MULTIPLE SCLEROSIS SIGNIFICANTLY REDUCED RELAPSE RATE IN TWO-YEAR PHASE III PIVOTAL TRIAL Geneva, Switzerland	English German French
13/01/2009	MERCK SERONO AND APITOPE ANNOUNCE LICENSING AGREEMENT ON NOVEL PEPTIDE THERAPEUTICS FOR THE TREATMENT OF MULTIPLE SCLEROSIS Geneva, Switzerland	English German French

2008
19/12/2008	MERCK SERONO AQUIRES MANUFACTURING RIGHTS AND FACILITY FOR STIMUVAX FROM ONCOTHYREON Geneva, Switzerland	English
09/12/2008	MERCK SERONO’S KUVAN® RECEIVES MARKETING AUTHORIZATION IN EUROPE Geneva, Switzerland	English German French
01/12/2008	MERCK SERONO: EUROPEAN COMMISSION APPROVES ERBITUX FOR FIRST-LINE USE IN HEAD AND NECK CANCER Geneva, Switzerland	English
13/11/2008	MERCK SERONO: OVERALL SURVIVAL IN FIRST-LINE NSCLC REACHES 15 MONTHS WITH ERBITUX Geneva, Switzerland	English
12/11/2008	MERCK SERONO LAUNCHES EXPANSION OF FLAGSHIP BIOTECH CENTER TO MEET GROWING PATIENT NEEDS Geneva, Switzerland	English German French
29/10/2008	MERCK SERONO’S US AFFILIATE EMD SERONO, INC. AND THERATECHNOLOGIES ANNOUNCE COLLABORATION AND LICENSING AGREEMENT FOR TESAMORELIN IN THE UNITED STATES Geneva, Switzerland	English German
29/10/2008	MERCK SERONO AND LPATH FORM ALLIANCE FOR ASONEP Gerneva, Switzerland	English
24/10/2008	MERCK SERONO SUBMITS APPLICATION FOR GONAL-F® IN JAPAN FOR OVULATION INDUCTION IN INFERTILE WOMEN Gerneva, Switzerland	English German French
24/10/2008	MERCK SERONO: ERBITUX RECEIVES CHMP POSITIVE OPINION FOR FIRST-LINE USE IN HEAD AND NECK CANCER Geneva, Switzerland	English
14/10/2008	MICHAEL J. FOX FOUNDATION AWARDS $2 MILLION GRANT FROM MERCK SERONO TO RESEARCH PROJECTS ON COGNITIVE DEFICITS IN PARKINSON´S DISEASE Geneva, Switzerland	English German French
10/10/2008	MERCK SERONO NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE Geneva, Switzerland	English German French
03/10/2008	SEVERE ADVERSE EVENT REPORTED IN RAPTIVA® PATIENT Geneva, Switzerland	English German French
01/10/2008	MERCK SERONO AMONG THE WINNERS IN THE GERMAN BIOPHARMA STRATEGY COMPETITION Geneva, Switzerland	English German
29/09/2008	MERCK SERONO RECOGNIZED FOR STRATEGIC LEADERSHIP IN HUMAN RESOURCES Geneva, Switzerland	English German French
26/09/2008	MERCK SERONO´S KUVAN® RECOMMENDED FOR EUROPEAN APPROVAL Geneva, Switzerland	English German French
23/09/2008	MERCK SERONO ANNOUNCES ONE-MONTH RESULTS OF PHARMACOGENOMICS STUDY PREDICT AT 47TH ANNUAL MEETING OF THE EUROPEAN SOCIETY FOR PAEDIATRIC ENDOCRINOLOGY Geneva, Switzerland	English German French
22/09/2008	RESULTS FROM IMPROVE STUDY SHOW THERAPEUTIC EFFECT OF NEW FORMULATION OF REBIF® AT 16 WEEK IN PATIENTS WITH MULTIPLE SCLEROSIS Geneva, Switzerland	English German French
18/09/2008	MERCK SERONO ANNOUNCES INITIATION OF THE ORACLE MS TRIAL TO EVALUATE CLADRIBINE TABLETSIN PATIENTS AT RISK OF DEVELOPING MULTIPLE SCLEROSIS Geneva, Switzerland	English German French
17/09/2008	MERCK SERONO COMPLETES ENROLLMENT IN THE REFLEX TRIAL OF REBIF® IN PATIENTS AT RISK OF DEVELOPING MULTIPLE SCLEROSIS Geneva, Switzerland	English German French
11/09/2008	MERCK SERONO SUBMITS NEW LICENSE APPLICATION FOR ERBITUX IN FIRST-LINE NON-SMALL CELL LUNG CANCER IN EUROPE Geneva, Switzerland	English
10/09/2008	GLUCOPHAGE® POWDER FOR ORAL SOLUTION IN SACHET RECEIVES POSITIVE OPINION FOR APPROVAL IN EUROPE Geneva, Switzerland	English German French
04/09/2008	MERCK SERONO AND ABLYNX ENTER INTO AN AGREEMENT TO CO-DISCOVER AND CO-DEVELOP NANOBODIES® Geneva, Switzerland	English German French
03/09/2008	MERCK SERONO AND ZYMOGENETICS RESTRUCTURE PARTNERSHIP Geneva, Switzerland	English German French
16/07/2008	MERCK SERONO: ERBITUX APPROVED FOR USE IN METASTATIC COLORECTAL CANCER IN JAPAN Geneva, Switzerland	English
09/07/2008	MERCK SERONO: ERBITUX® PHASE III CLINICAL STUDY IN GASTRIC CANCER STARTED Geneva, Switzerland	English
01/07/2008	EMEA CONFIRMS POSITIVE BENEFIT-RISK BALANCE WITH RAPTIVA® FOR THE TREATMENT OF PSORIASIS Geneva, Switzerland	English German French
19/06/2008	MERCK SERONO APPLIES TO EXTEND USE OF ERBITUX FOR FIRST-LINE HEAD AND NECK CANCER IN EUROPE Geneva, Switzerland	English
18/06/2008	MERCK SERONO AND BIONOMICS ANNOUNCE MULTIPLE SCLEROSIS DEVELOPMENT AND LICENSING AGREEMENT Geneva, Switzerland	English German French
18/06/2008	RENOUVELLEMENT DE LA CERTIFICATION ENVIRONNEMENTALE DU SITE DE PRODUCTION DE MERCK SERONO À CORSIER-SUR-VEVEY Genève, Suisse	German French
10/06/2008	MERCK SERONO STRENGTHENS ITS PRESCRIPTION MEDICINES PORTFOLIO IN LATIN AMERICA Geneva, Switzerland	English German French
10/06/2008	MERCK SERONO’S REBIF® CELEBRATES 10TH ANNIVERSARY Geneva, Swizterland	English German French
05/06/2008	MERCK SERONO ANNOUNCES INITIATION OF SECOND PHASE II/III CLINICAL STUDY OF ATACICEPT IN LUPUS Geneva, Switzerland	English German French
31/05/2008	MERCK SERONO: ERBITUX SIGNIFICANTLY PROLONGS SURVIVAL IN FIRST-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER Geneva, Switzerland	English
30/05/2008	MERCK SERONO A DÉPOSÉ LA DERNIÈRE DEMANDE DE PERMIS DE CONSTRUIRE RELATIVE AU PROJET D’EXTENSION DE SON SITE DE PRODUCTION DE CORSIER-SUR-VEVEY Genève, Suisse	German French
15/05/2008	PROJET D’EXTENSION DU SITE DE MERCK SERONO À CORSIER-SUR-VEVEY : CONCLUSIONS DE LA NOTICE D’IMPACT SUR L’ENVIRONNEMENT Genève, Suisse	German French
05/05/2008	UNIQUE THREE-YEAR DATA DEMONSTRATING LONG-TERM EFFICACY AND SAFETY OF RAPTIVA® IN THE TREATMENT OF PSORIASIS PUBLISHED IN THE BRITISH JOURNAL OF DERMATOLOGY Geneva, Switzerland	English German French
30/04/2008	MERCK SERONO ANNOUNCES INITIATION OF PHASE II CLINICAL TRIAL OF ATACICEPT IN RELAPSING MULTIPLE SCLEROSIS Geneva, Switzerland	English German French
16/04/2008	MERCK ANNOUNCES PLANNED INVESTMENT OF $50 MILLION IN RESEARCH CENTER IN THE US Geneva, Switzerland	English German French

2007
20/12/2007	MERCK SERONO AND FLAMEL TO COLLABORATE ON AN EXTENDED RELEASE FORMULATION FOR THERAPEUTIC PROTEINS Geneva, Switzerland	English German French
19/12/2007	MERCK KGAA IDERA PHARMACEUTICALS TO COLLABORATE ON DEVELOPMENT OF TLR9 AGONISTS FOR TREATMENT OF CANCER Geneva, Switzerland	English German
18/12/2007	MERCK SERONO LAUNCHES NEW WEBSITE Geneva, Switzerland	English German French
13/12/2007	MERCK SERONO ANNOUNCES SUPPORT OF THE MICHAEL J. FOX FOUNDATION FOR PARKINSON’S RESEARCH Geneva, Switzerland	English German French
13/12/2007	MERCK SERONO ANNOUNCES INITIATION OF PHASE II/III CLINICAL TRIAL OF ATACICEPT IN LUPUS NEPHRITIS Geneva, Switzerland	English German French
29/11/2007	NEW DATA HIGHLIGHT THAT TREATMENT WITH ERBITUX ALLOWS MORE RESECTIONS OF PRETREATED PATIENTS WITH METASTATIC COLORECTAL CANCER Geneva, Switzerland	English
29/11/2007	MERCK SERONO’S CYANOKIT® APPROVED IN THE EUROPEAN UNION Geneva, Switzerland	English German French
28/11/2007	MERCK SERONO INITIATES THE MOTION STUDY, A NEW PHASE III CLINICAL TRIAL OF SAFINAMIDE IN PARKINSON’S DISEASE Geneva, Switzerland	English German French
14/11/2007	STUDY PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE SHOWS ERBITUX IMPROVES SURVIVAL IN METASTATIC COLORECTAL CANCER Geneva, Switzerland	English
08/11/2007	MERCK SERONO SUBMITS EUROPEAN MARKETING AUTHORIZATION APPLICATION FOR SAPROPTERIN AS A TREATMENT FOR HYPERPHENYLALANINEMIA Geneva, Switzerland	English German French
08/11/2007	FDA APPROVAL OF EASYPOD®: NEW ELECTRONIC GROWTH HORMONE INJECTION DEVICE Geneva, Switzerland	English German French
31/10/2007	MERCK SERONO AND EPFL ANNOUNCE RESEARCH PARTNERSHIP IN NEUROSCIENCE, ONCOLOGY AND DRUG DELIVERY Geneva, Switzerland	English German French
17/10/2007	MERCK SERONO ANNOUNCES JOINT AGREEMENT WITH IMCLONE AND BRISTOL-MYERS SQUIBB FOR ERBITUX IN JAPAN Geneva, Switzerland	English
11/10/2007	TWO-YEAR PHASE IIIB DATA SHOW THAT THE NEW FORMULATION OF REBIF® OFFERS A NEAR THREE-FOLD IMPROVEMENT IN INJECTION TOLERABILITY AND REDUCED IMMUNOGENICITY Geneva, Switzerland	English German French
26/09/2007	DATA REINFORCE THE VALUE OF UFT® AS AN IMPORTANT TREATMENT OPTION FOR PATIENTS WITH METASTATIC COLORECTAL CANCER Geneva, Switzerland	English
25/09/2007	SAFETY AND EFFICACY OF ERBITUX® CONFIRMED FOR COMBINATION TRIALS Geneva, Switzerland	English
24/09/2007	MERCK SERONO’S CYANOKIT® RECOMMENDED FOR EUROPEAN APPROVAL Geneva, Switzerland	English German
11/09/2007	ERBITUX PHASE III STUDY – FLEX INCREASES OVERALL SURVIVAL IN FIRST-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER Geneva, Switzerland	English
05/09/2007	STIMUVAX® THERAPEUTIC CANCER VACCINE – PHASE II DATA HIGHLIGHT THREE-YEAR SURVIVAL RESULTS FOR LUNG CANCER PATIENTS Geneva, Switzerland	English
03/09/2007	MERCK SERONO APPLIES TO EXTEND USE OF ERBITUX® FOR 1ST-LINE COLORECTAL CANCER Geneva, Switzerland	English
30/08/2007	NEW FORMULATION OF MULTIPLE SCLEROSIS TREATMENT REBIF® APPROVED IN EUROPEAN UNION Geneva, Switzerland	English German French
29/08/2007	MERCK SERONO TO RECONSIDER DEVELOPMENT OF MATUZUMAB IN METASTATIC COLORECTAL CANCER PATIENTS Geneva, Switzerland	English
22/08/2007	MERCK SERONO ANNOUNCES 18-MONTH SAFETY AND EFFICACY DATAOF PHASE III TRIAL OF SAFINAMIDE IN PARKINSON’S DISEASE Geneva, Switzerland	English
06/07/2007	SQUEEZE OUT OF MERCK SERONO SHARES SUCCESSFULLY COMPLETED Geneva, Switzerland	English German French
29/06/2007	MERCK SERONO’S FERTILITY TREATMENT PERGOVERIS™ APPROVED IN EUROPEAN UNION Geneva, Switzerland	English German French
28/06/2007	EUROPEAN UNION CHMP RECOMMENDS APPROVAL OF NEW FORMULATION OF MULTIPLE SCLEROSIS TREATMENT REBIF® (INTERFERON BETA-1A) Geneva, Switzerland	English German French
19/06/2007	MERCK SERONO AND AMBRX TO COLLABORATE ON DEVELOPMENT OF NEXT GENERATION GROWTH HORMONE PRODUCTS Geneva, Switzerland	English German French
18/06/2007	EASYPOD™ PATIENT FRIENDLY INJECTION DEVICE RECOGNIZED BY TECHNOLOGY AWARD Geneva, Switzerland	English German French
15/06/2007	INAUGURATION OF MERCK SERONO’S NEW GLOBAL HEAD OFFICE IN GENEVA Geneva, Switzerland	English German French
08/06/2007	PROMISING DATA ON COGNITIVE EFFECTS OF SAFINAMIDEIN EARLY PARKINSON’S DISEASE Geneva, Switzerland	English German French
04/06/2007	MERCK SERONO S.A. TO TERMINATE REGISTRATION AND DUTY TO FILE REPORTS UNDER THE U.S. SECURITIES EXCHANGE ACT Geneva, Switzerland	English German French
04/06/2007	CLOSING OF THE EXISTING SHARE-REPURCHASE PROGRAM OF UP TO CHF 750 MILLION BY JUNE 1, 2007 Geneva, Switzerland	English French
16/05/2007	INAUGURATION DE L’ESPACE DE VIE ENFANTINE CRESCENDO Genéve, Suisse	French
02/05/2007	PHASE III DATA ON SAFINAMIDE IN PARKINSON'S DISEASE PRESENTED AT AMERICAN ACADEMY OF NEUROLOGY 59TH ANNUAL MEETING Geneva, Siwtzerland	English French
27/04/2007	MERCK SERONO ANNOUNCES PRESENTATION OF PHASE III CLINICAL DATA ON SAFINAMIDE IN PARKINSON’S DISEASE AT THE AMERICAN ACADEMY OF NEUROLOGY 59TH ANNUAL MEETING Geneva, Switzerland	German French
05/04/2007	MERCK SERONO S.A. TO VOLUNTARILY DELIST AND DEREGISTER ITS BEARER SHARES AND AMERICAN DEPOSITARY SHARES (EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS) Geneva, Switerland	English German French
21/03/2007	MERCK SERONO CONFIRMS PREVIOUSLY ANNOUNCED 2006 FIGURES Geneva, Switzerland	English German French
21/03/2007	MERCK INITIATES SQUEEZE OUT PROCEDURE FOR SHARES OF MERCK SERONO S.A. Geneva, Switzerland	English German French
01/03/2007	MERCK KGAA ANNOUNCES SERONO PRELIMINARY FIGURES FOR 2006 Geneva, Switzerland	English German French
28/02/2007	MERCK KGAA HOLDS NEARLY ALL VOTING RIGHTS IN MERCK SERONO S.A. Geneva, Switzerland	English
30/01/2007	MERCK SERONO LAUNCHES EASYPOD®, FIRST ELECTRONIC GROWTH HORMONE INJECTION DEVICE Geneva, Switzerland	English German French
24/01/2007	MERCK SERONO HAS INITIATED THE ONWARD STUDY TO EVALUATE ORAL CLADRIBINE AS ADD-ON TREATMENT FOR MULTIPLE SCLEROSIS Geneva, Switzerland	English German French
16/01/2007	MERCK SERONO COMPLETES PATIENT ENROLLMENT IN CLARITY PHASE III PIVOTAL CLINICAL TRIAL OF ORAL CLADRIBINE Geneva, Switzerland	English German French
16/01/2007	MERCK SERONO ANNOUNCES POSITIVE RESULTS FROM PHASE III DIET STUDY OF PHENOPTIN FOR PHENYLKETONURIA Geneva, Switzerland	English German French
09/01/2007	MERCK KGAA ANNOUNCES PUBLIC TENDER OFFER FOR MERCK SERONO SHARES Darmstadt, Germany	English
08/01/2007	MERCK SERONO IS LAUNCHED Geneva, Switzerland	English German French
05/01/2007	MERCK KGAA ACQUIRES MARJORITY SHAREHOLDING IN SERONO S.A. Geneva, Switzerland	English

SERVICES

Print Page